Topics

US FDA finds fault with standards at Aurobindo's oral solids facility

05:36 EST 3 Feb 2020 | in-PharmaTechnologis

Aurobindo Pharma reveals US FDA found objectionable conditions at its oral solids manufacturing facility.

Original Article: US FDA finds fault with standards at Aurobindo's oral solids facility

NEXT ARTICLE

More From BioPortfolio on "US FDA finds fault with standards at Aurobindo's oral solids facility"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...